Methods of Primary Tissue Culture and Drug Screening Using Autologous Serum and Fluids
AssigneeYao Tang
InventorYao Tang
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for culturing primary cells and tissues from a subject in the presence of the subject's own serum, ascites or pleural effusion fluid. Methods of treating cancer, and screening for the effectiveness or toxicity of drugs are also provided herein.
Claims10
A method for the primary culturing of solid tumor tissue from a subject, using the following steps in the order shown:
- A. obtaining the tissue from the subject;
- B. obtaining serum from the subject;
- C. embedding the tissue in a three dimensional autologous matrix by
- a) mixing one or more matrix proteins with serum from the subject at a ratio of approximately 1:1 to make an autologous matrix,
- b) coating the surface of a culture well or plate with a layer of the autologous matrix,
- c) placing the tissue onto the coated surface,
- d) adding a second layer of the autologous matrix onto the tissue, such that the tissue is immersed in the autologous matrix;
- and
- D. culturing the embedded tissue in a medium consisting essentially of 100% serum (v/v) from the subject.
A method for the primary culturing of cancer cells from the ascites or pleural effusion fluid of a subject, using the following steps in the order shown:
- A. obtaining the fluid from the subject;
- B. isolating the cells from the fluid while retaining the cell-free fluid;
- C. filtering the cell-free fluid to prevent protein clotting;
- D. building a three dimensional autologous structure by
- a) mixing one or more matrix proteins with the filtered, cell-free fluid at a ratio of approximately 1:1 to make an autologous matrix,
- b) coating the surface of a culture well or plate with the autologous matrix,
- E. seeding the isolated cells from step B onto the coated surface of step D;
- and
- F. culturing the seeded cells in a medium consisting essentially of 100% cell-free fluid (v/v) from step C.
A method for culturing circulating tumor cells (CTC) from the peripheral blood of a subject, using the following steps in the order shown:
- A. obtaining blood from the subject;
- B. isolating a cell population containing both CTC and the peripheral blood mononuclear cells (PBMC) from the subject's blood, while retaining the serum;
- C. building a three dimensional autologous structure by
- a) mixing one or more matrix proteins with the serum from step B at a 1:1 ratio to make an autologous matrix,
- b) coating the surface of a culture well or plate with the autologous matrix,
- D. seeding the cells from step B onto the coated surface of step C,
- E. culturing the seeded cells in a medium consisting essentially of 100% serum (v/v) from the subject.
Dependencies are inferred from the claim text.